Treatment of Binge Eating in Obese Patients in Primary Care
Conditions
Binge Eating | Obesity
Trial Phase
Phase 4
Trial Purpose and Description
Trial Purpose
This study will test the effectiveness of two empirically-supported but distinct treatments for recurrent binge eating in obese patients: 1) Cognitive Behavior Therapy, using a pure self-help approach and 2) sibutramine, an anti-obesity medication also found to have efficacy for binge eating. Self-help Cognitive Behavior Therapy and sibutramine will be administered alone and in combination in a primary care setting.
Participation Guidelines
- Age:
- 18 Years - 60 Years
- Gender:
- Both
Eligibility Criteria
Inclusion Criteria:
- Obese (BMI >= 30)
Exclusion Criteria:
- Medication regimen that represents medical contraindication to sibutramine
- Serious unstable or uncontrolled medical conditions that represent contraindication
to sibutramine
- Pregnancy
- Sponsor:
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- National Institutes of Health (NIH)
- Yale University
- Dates:
- September 2007
- Last Updated:
- January 13, 2010
- Study HIC#:
- 0501027352
Clinicaltrials.gov ID: NCT00537810
